Cost-Utility Analysis Of Abiraterone Versus Enzalutamide In The Treatment Of Metastatic Castration-Resistant Prostate Cancer After Failure Of Androgen Deprivation Therapy

AuthID
P-00R-G10
3
Author(s)
Paquete, AT
·
Borges, M
Tipo de Documento
Abstract
Year published
2019
Publicado
in VALUE IN HEALTH, ISSN: 1098-3015
Volume: 22, Páginas: S611-S612 (2)
Indexing
Publication Identifiers
Wos: WOS:000503167001349
Source Identifiers
ISSN: 1098-3015
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.